BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33571894)

  • 1. A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies.
    Hiemenz MC; Oberley MJ; Doan A; Aye L; Ji J; Schmidt RJ; Biegel JA; Bhojwani D; Raca G
    Cancer Genet; 2021 Jun; 254-255():25-33. PubMed ID: 33571894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
    Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
    Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
    Levy MA; Santos S; Kerkhof J; Stuart A; Aref-Eshghi E; Guo F; Hedley B; Wong H; Rauh M; Feilotter H; Berardi P; Semenuk L; Yang P; Knoll J; Ainsworth P; McLachlin CM; Chin-Yee I; Kovacs M; Deotare U; Lazo-Langner A; Hsia C; Keeney M; Xenocostas A; Howlett C; Lin H; Sadikovic B
    Eur J Haematol; 2019 Sep; 103(3):178-189. PubMed ID: 31177553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia.
    Akkari YMN; Bruyere H; Hagelstrom RT; Kanagal-Shamanna R; Liu J; Luo M; Mikhail FM; Pitel BA; Raca G; Shago M; Shao L; Smith LR; Smolarek TA; Yenamandra A; Baughn LB
    Cancer Genet; 2020 May; 243():52-72. PubMed ID: 32302940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders.
    Pugh TJ; Fink JM; Lu X; Mathew S; Murata-Collins J; Willem P; Fang M;
    Cancer Genet; 2018 Dec; 228-229():184-196. PubMed ID: 30393007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IKZF1
    Kovach AE; Wengyn M; Vu MH; Doan A; Raca G; Bhojwani D
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30996. PubMed ID: 38637852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia.
    Hutspardol S; Pakakasama S; Kanta K; Nuntakarn L; Anurathapan U; Sirachainan N; Songdej D; Sawangpanich R; Tiyasirichokchai R; Rerkamnuaychoke B; Hongeng S
    Int J Lab Hematol; 2013 Aug; 35(4):406-15. PubMed ID: 23190578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
    Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
    Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia.
    Aypar U; Smoley SA; Pitel BA; Pearce KE; Zenka RM; Vasmatzis G; Johnson SH; Smadbeck JB; Peterson JF; Geiersbach KB; Van Dyke DL; Thorland EC; Jenkins RB; Ketterling RP; Greipp PT; Kearney HM; Hoppman NL; Baughn LB
    Eur J Haematol; 2019 Jan; 102(1):87-96. PubMed ID: 30270457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
    Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics.
    Engvall M; Cahill N; Jonsson BI; Höglund M; Hallböök H; Cavelier L
    BMC Med Genomics; 2020 Jul; 13(1):106. PubMed ID: 32727569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies.
    Koduru P; Chen W; Fuda F; Kaur G; Awan F; John S; Garcia R; Gagan J
    Clin Pathol; 2024; 17():2632010X241230262. PubMed ID: 38371338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
    Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
    Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
    Liu YF; Wang BY; Zhang WN; Huang JY; Li BS; Zhang M; Jiang L; Li JF; Wang MJ; Dai YJ; Zhang ZG; Wang Q; Kong J; Chen B; Zhu YM; Weng XQ; Shen ZX; Li JM; Wang J; Yan XJ; Li Y; Liang YM; Liu L; Chen XQ; Zhang WG; Yan JS; Hu JD; Shen SH; Chen J; Gu LJ; Pei D; Li Y; Wu G; Zhou X; Ren RB; Cheng C; Yang JJ; Wang KK; Wang SY; Zhang J; Mi JQ; Pui CH; Tang JY; Chen Z; Chen SJ
    EBioMedicine; 2016 Jun; 8():173-183. PubMed ID: 27428428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
    Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
    Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution Chromosomal Microarray Analysis (CMA) enhances the genetic profile of pediatric B-cell Acute Lymphoblastic Leukemia patients.
    Mitrakos A; Kattamis A; Katsibardi K; Papadhimitriou S; Kitsiou-Tzeli S; Kanavakis E; Tzetis M
    Leuk Res; 2019 Aug; 83():106177. PubMed ID: 31261022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches.
    Kim B; Kim E; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR
    Hematol Oncol; 2020 Feb; 38(1):82-88. PubMed ID: 31875988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients.
    Akhter A; Mughal MK; Elyamany G; Sinclair G; Azma RZ; Masir N; Shuib S; Rashid-Kolvear F; Shabani-Rad MT; Stewart DA; Mansoor A
    Diagn Pathol; 2016 Sep; 11(1):89. PubMed ID: 27632978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
    Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
    Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
    DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
    Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.